Octreotide for nausea and vomiting after chemotherapy and stem-cell transplantation [8]

Lancet

Volumn 353, Issue 9155, 1999, Pages 846-

  Nordesjo Haglund, G ^a   Lonnqvist, B ^a   Lindberg, G ^a   Hellstrom Lindberg, E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERYTHROMYCIN; OCTREOTIDE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MOTOR ACTIVITY; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STOMACH MOTILITY; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

EID: 0033528485     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)76666-6     Document Type: Letter

References (5)

1. RE Brand JK DiBaise EMM Quigley Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation Lancet 352 1998 1985
2. JR Hecht T Lembo L Chap Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma Cancer 79 1997 1698 1702
3. HC Soudah WL Hasler C Owayang Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma N Engl J Med 325 1991 1461 1467
4. G Nordesjö P Ljungman B Björkstrand G Lindberg E Hellström-Lindberg Treatment of long-term anorexia and nausea after stem cell transplantation with low-dose octreotide Bone Marrow Trans 21 suppl 1 1998 S89
5. T Peeters G Matthijs I Depoortere T Cachet J Hoogmartens G Vantrappen Erythromycin is a motilin receptor agonist Am J Physiol 257 1989 G470 G474